Ardent Health Partners, Inc. (ARDT) Reports Q3 Loss of $0.17, provides guidance

Ardent Health Partners, Inc. (NYSE: ARDT) reported Q3 EPS of ($0.17). Revenue for the quarter came in at $1.58 billion, versus $0 reported last year.

GUIDANCE:

Ardent Health Partners, Inc. sees FY2025 EPS of $0.85-$1.03, versus the consensus of $1.86. Ardent Health Partners, Inc. sees FY2025 revenue of $6.2-6.45 billion, versus the consensus of $6.348 billion.

For earnings history and earnings-related data on Ardent Health Partners, Inc. (ARDT) click here.

You May Also Be Interested In

• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• RCM Technologies (RCMT) Tops Q2 EPS by 17c
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c